Skip to main content

ORIGINAL RESEARCH article

Front. Med., 22 November 2022
Sec. Dermatology

Expression patterns of hair-related keratins and epithelial keratins in onychopapilloma: The significance of clarifying the origin of onychopapilloma

\r\nMengxi Liu,&#x;Mengxi Liu1,2†Fang Li&#x;Fang Li1†Xiaoqing Wang&#x;Xiaoqing Wang1†Zhenru LiuZhenru Liu1Hoi Shiwn WongHoi Shiwn Wong1Yuan Zhou,Yuan Zhou1,3Daguang Wang*Daguang Wang1*
  • 1Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
  • 2Department of Dermatology, Suzhou Municipal Hospital East Area, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China
  • 3Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing, China

Background: Onychopapilloma is generally recognized as a benign tumor of the nail bed and distal matrix. However, the origin of onychopapilloma has not been explained yet.

Objective: To clarify the origin of onychopapilloma, we detected the expression patterns of hair-related keratins and epithelial keratins, which are expressed specifically in the nail unit.

Materials and methods: The clinical and histopathologic features of 11 patients with onychopapilloma were analyzed, and the expression patterns of hair-related and epithelial keratins were detected.

Results: Histologically, all subjects showed acanthosis, papillomatosis and matrix metaplasia within the nail bed. Immunohistochemically, the expression pattern of keratins in our standard nail unit was consistent with previous reports. “Nail matrix-related keratins” HK31, HK34, HK85, and HK86 were only expressed in the nail matrix, and “Nail bed-related keratins” HK75 and K6/K16 were only expressed in the nail bed. However, in onychopapilloma, whether adjacent to the matrix or in the distal nail bed, all cases were positive for nail bed-related keratins and HK31 but negative for other nail matrix-related keratins.

Conclusion: Our study suggests that onychopapilloma may originate from the nail bed rather than the nail matrix. Furthermore, the expression of nail bed-related keratins and HK31 could be used as diagnostic markers of onychopapilloma.

Introduction

Onychopapilloma is recognized as a benign tumor of the nail bed and distal nail matrix. It was first described as “localized multinucleate distal subungual keratosis” by Baran and Perrin (1), and the term “onychopapilloma” was proposed in 2000 (2). It usually occurs on the thumbs of adults (3). Although Kim et al. conjectured that onychopapilloma could be neoplastic hyperplasia of the nail bed epithelium or reactive hyperplasia of the nail bed epithelium due to chronic irritation, trauma or other inflammatory nail diseases (4), there is no definite evidence of this. Whether the onychopapilloma originates from the nail bed, the nail matrix, or both are discussed in this study.

The nail bed is different from the nail matrix in histology and embryology, and there is no transformation between the developed nail bed and the nail matrix. Anatomically, the nail unit is usually recognized as an equivalent of the follicle. Some authors claimed that the nail bed is equivalent to the outer root sheath of the follicle and that the nail matrix is comparable to the hair matrix (5, 6). In recent studies, the expression profiles of hair-related and epithelial keratins have been determined in the human nail unit (69). The nail matrix was the only site of expression of hair-related keratins, including HK31, HK34, HK85, and HK86, which could not be detected in the nail bed and hyponychium. HK75, K6, and K16 were explicitly expressed in the nail bed. The unique expression pattern of hair-related keratins and epithelial keratins in the nail unit could be used to identify the differentiation of nail matrix epithelium and nail bed epithelium. However, a comprehensive immunohistochemical analysis of keratin expression in onychopapilloma has not been performed. To define the origin of onychopapilloma, we analyzed the pathologic characteristics of this disease and the expression patterns of hair-related keratins and epithelial keratins in the involved tissue. Furthermore, we hope to search for special markers of onychopapilloma.

Materials and methods

Tissue samples

All subjects gave their informed consent for inclusion before they participated in the study. The study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved by the Ethics Committee of the First Affiliated Hospital of Nanjing Medical University (IRB-GL1-AF05; 2021-NT-32).

Surgically resected specimens from 11 cases with onychopapilloma treated between August 2019 and May 2021 at the Department of Dermatology in the First Affiliated Hospital of Nanjing Medical University were used for this study. The following features were recorded: age, sex, affected nail(s) location, and clinical presentations. We performed two types of biopsies according to the actual situation: (1) incision biopsies extending from the distal nail matrix to the hyponychium, including the nail matrix, the nail bed, the proximal nail fold and the hyponychium; and (2) longitudinal biopsies, in which the scope is the same as the biopsy after nail avulsion. All samples were fixed in 4% buffered formalin and embedded in paraffin. We selected seven standard nails as the control (normal nail unit tissue specimen around the skin lesion after nail matrix nevi excision).

Immunohistochemistry

All antibodies were first assayed on formalin-fixed and paraffin-embedded scalp sections to demonstrate their correct reactivity relative. The following hair-related keratins and epithelial keratins were used for the immunohistochemical analysis: HK31 (1:1,000; Thermo Fisher, Massachusetts, USA), HK34 (1:400; Progen), HK 85 (1:400; Progen, Heidelberg, Germany), HK 86 (1:400; Progen), HK75 (1:200; Thermo Fisher) and K6/K16 (1:300; Thermo Fisher). SP methods were employed to perform the immunohistochemical staining, and the steps were performed according to the standard protocol.

Results

Clinical presentations

Eleven onychopapilloma cases were identified (Table 1), including six females and five males ranging from 13 to 54 (mean, 30.7) years of age. The thumb was the most affected digit (n = 6). Subungual hyperkeratosis and a longitudinal band were the most common clinical presentations (Figure 1). In all cases, the longitudinal band corresponded to the keratotic mass under the nail plate. Splinter hemorrhages with longitudinal erythronychia were observed in 2 cases, and V-shaped notches and splitting of the distal nail plate were observed in another 2 cases.

TABLE 1
www.frontiersin.org

Table 1. Clinical presentations of onychopapilloma.

FIGURE 1
www.frontiersin.org

Figure 1. Common clinical presentations of onychopapilloma. (A) Subungual keratotic mass. (B) Longitudinal erythronychia.

Pathology

In all cases, the most obvious histological presentation of specimens was papillomatosis with or without acanthosis of the distal nail bed epithelium (Figure 2). Most cases showed focal proliferation of epithelial cells with abundant eosinophilic cytoplasm in the upper layers of the nail bed epithelium (matrix metaplasia), which resembles the keratogenous zone of the matrix. In some cases, dyskeratosis cells could be observed in the superficial layer of the nail bed epithelium. Subungual hyperkeratosis could be seen under the distal nail plate in the longitudinal biopsy specimens. However, there was no obvious abnormality in the nail matrix in 11 cases.

FIGURE 2
www.frontiersin.org

Figure 2. Longitudinal sections; the pathological features of onychopapilloma. (A) Papillomatosis of the distal nail bed epithelium (HE, ×100). (B) The scanning magnification shows the upper layers of the nail bed contains cells resembling those of the keratogenous zone of the matrix (HE, ×400).

Immunohistochemical study

The immunohistochemical results showed the same expression pattern of hair-related keratins and epithelial keratins in the standard nail unit as in previous reports, which was similar to their sequential expression in the hair follicle cortex (Table 2). HK31, HK34, HK85, and HK86 were consecutively expressed in the keratogenous zone of the distal nail matrix. The expression of HK75 was only observed in the nail bed. K6/K16 was expressed in the apical nail matrix and the nail bed but still not in the distal nail matrix.

TABLE 2
www.frontiersin.org

Table 2. Hair-related keratins and epithelial keratins expression in the normal nail unit and onychopapilloma.

Of all the onychopapilloma cases, hair-related keratins, including HK34, HK85, and HK86, still showed negative expression in the nail bed (Table 3). However, all onychopapilloma cases showed positive expression of HK31 (Figure 3), whether adjacent to the matrix or in the distal nail bed (Figure 4). As expected, “nail bed-related keratins” HK75 and K6/K16 were positively expressed in onychopapilloma, especially papillomatosis with acanthosis of the distal nail bed epithelium (Table 3).

TABLE 3
www.frontiersin.org

Table 3. Hair-related keratins and epithelial keratins expression in the nail bed of onychopapilloma.

FIGURE 3
www.frontiersin.org

Figure 3. Longitudinal sections; expression of HK31 in the normal nail unit and onychopapilloma. (A) Normal nail matrix (DAB staining, SP, ×400). (B) Normal nail bed (DAB staining, SP, ×400). (C) Nail bed of onychopapilloma (DAB staining, SP, ×400).

FIGURE 4
www.frontiersin.org

Figure 4. Longitudinal sections; expression of HK31, HK75, and K6/K16 in the nail bed of the onychopapilloma. (A) Expression of HK31 (DAB staining, SP, ×40). (B) Expression of HK75 (DAB staining, SP, ×40). (C) Expression of K6/K16 (DAB staining, SP, ×40).

Discussion

Baran and Perrin first reported four subungual keratosis cases with multinucleated cell aggregation according to pathological morphology and named the condition “local multinucleated distal keratosis” in 1995 (1). In 2000, they reported another 14 cases with longitudinal erythronychia and suggested that the term “local multinucleated distal keratosis” should be replaced by “onychopapilloma” (2). Onychopapilloma usually occurs in adults and most commonly in the thumb (2).

Clinically, onychopapilloma typically presents as longitudinal erythronychia with subungual hyperkeratosis. It can also present as longitudinal melanonychia, longitudinal leukonychia, splinter hemorrhages or onycholysis. Although the longitudinal streak can extend from the free edge of the nail plate to the lunula, this does not suggest that onychopapilloma originates from the nail matrix. Halteh suggested that longitudinal erythronychia may be due to the tumor compression of the nail bed causing local nail plate thinning and the formation of the lower erythema (10). The longitudinal leukonychia may be caused by the photorefraction change and fibrosis of the nail bed epithelium. And longitudinal melanonychia may be associated with the activation of melanocytes stimulated by the tumor. Therefore, the specific location and origin of onychopapilloma cannot be determined only through clinical manifestations. The keratotic mass under the nail plate corresponds to the position of the longitudinal streak. The dermoscopic examination can more clearly show the asymmetric keratotic mass under the nail plate with excessive lamellar keratinization. Splinter hemorrhages were observed in some patients, presenting continuous or discontinuous, single or multiple. Therefore, the dermoscopic examination is very important in the diagnosis of onychopapilloma.

In previous studies of onychopapilloma, it was recognized as a benign neoplasm originating from the distal nail matrix. However, the etiology and pathogenesis of onychopapilloma have not reached a consensus yet. Anatomically, the nail bed is different from the nail matrix, and there is no transformation between the two. We hope to determine whether onychopapilloma originates from the nail bed, nail matrix, or both.

On histological grounds, onychopapilloma is characterized by acanthosis and papillomatosis within the nail bed and abundant eosinophilic cytoplasm in the upper cell layers of the nail bed epithelium (matrix metaplasia) (24, 1012). Sometimes, matrix metaplasia cannot be observed because of the surgical method or the quality of the specimen. Thus, in other disease premises, the diagnosis could be made histologically based on acanthosis and papillomatosis within the nail bed epithelium. Additionally, histopathology showed that onychopapilloma was a mixed growth acanthoma that can secrete large amounts of eosinophilic keratin (13). It is associated with subungual hyperkeratosis or subungual keratotic mass. Histologically, hyperkeratosis and parakeratosis are helpful in diagnosis.

The differential diagnosis of onychopapilloma mainly includes Bowen’s disease, glomus tumor, Darier disease, and melanoma. There is no distal subungual keratosis in Bowen’s disease, and the pathological features are obvious, with typical anomalous epidermal cells and dyskeratosis cells. Glomus tumor patients usually have severe pain and no distal subungual hyperkeratosis. Longitudinal erythronychia is also a typical manifestation of Darier disease, but it usually involves more than one finger and is often accompanied by longitudinal leukonychia. When onychopapilloma presents as longitudinal melanonychia, the pathological examination should be performed to eliminate melanoma. Usually, clinical manifestation, dermatoscopy, and histopathological examination are sufficient to confirm the diagnosis of onychopapilloma. However, because of the particularity of the histology of the nail unit, it is challenging to distinguish onychopapilloma from other onycho-tumors, such as onychocytic matricoma and onychomatricoma. In these circumstances, the immunohistochemical feature is helpful.

We studied 11 cases of onychopapilloma and confirmed that all histopathologic changes of onychopapilloma were seen in the nail bed rather than the nail matrix. Therefore, we preliminarily conjecture that the onychopapilloma originates from the nail bed.

In recent studies, the expression profiles of hair-related keratins and epithelial keratins have been determined in the standard nail unit (69). Hair-related keratins, including HK31, HK34, HK85, and HK86, were specifically expressed in the nail matrix and nail plate but not in the standard nail bed or nail fold. The expression of HK75 was supposed to be limited in the superbasal nail bed epithelium, and K6/K16 was expressed both in the nail bed and eponychium. The special expression pattern of hair-related keratins and epithelial keratins in the nail unit could be used to identify the differentiation of nail matrix epithelium and nail bed epithelium. Thus, we performed an immunohistochemical study to clarify the origin of onychopapilloma. There was no significant difference between the proximal and distal parts of the tumor (Figure 4), so we selected the more prominent portion of the tumor at the distal nail bed. The results showed that HK75 and K6/K16 were strongly expressed positively in the nail bed, especially papillomatosis with acanthosis of the nail bed epithelium. In contrast, hair-related keratins, including HK34, HK85, and HK86, showed negative expression in onychopapilloma. This indicated that onychopapilloma is a benign tumor of the nail bed rather than the nail matrix. Subungual hyperkeratosis was formed by keratin accumulation produced by neoplastic hyperplasia of the nail bed epithelium. However, the expression of HK31 requires an explanation. HK31 was supposed to be expressed only in the nail matrix. Our study showed that it was expressed both in the standard nail matrix and the involved nail bed epithelium, especially in the superficial layer of the nail bed (matrix metaplasia). Previously, the structure of the nail unit is usually recognized as an equivalent of the follicle. In the hair matrix, HK85 is the marker protein that showed persistent positive expression. HK31 is early cortex keratin in the inferior part of the hair cortex, the expression of which disappears at an early stage. While HK86 and HK34 are late cortex keratins in the upper part of the hair cortex, which express at the late stages (14). By analogy with hair follicles, we suspect that the expression of HK31 may be associated with matrix metaplasia of the nail bed epithelium, which leads to an increased ability of the nail bed to produce keratin.

To our knowledge, the current study is the first clinical research to explore the origin of onychopapilloma by immunohistochemistry to date. From our result, the specific expression of HK31, the positive expression of “nail bed-related keratin” (HK75, K6/K16) and the negative expression of “nail matrix-related keratin” (HK34, HK85, and HK86) could be the immunohistochemical characteristic of onychopapilloma. Based on the specific expression of HK31 in the nail bed, we speculate that HK31 can also be used as a marker for the differential diagnosis of onychopapilloma and other nail bed tumors.

Conclusion

Our study suggests that onychopapilloma may originate from the nail bed epithelium. The histopathological characteristics of onychopapilloma include papillomatosis, acanthosis and matrix metaplasia of the nail bed epithelium rather than the nail matrix. In immunohistochemistry, onychopapilloma showed positive expression of HK31 and “nail bed-related keratin,” with negative expression of other “nail matrix-related keratin,” which may provide a new approach for the differential diagnosis of onychopapilloma.

Data availability statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Ethics statement

The studies involving human participants were reviewed and approved by the Ethics Committee of the First Affiliated Hospital with Nanjing Medical University, Nanjing, China. The patients/participants provided their written informed consent to participate in this study.

Author contributions

DW: conceptualization, funding acquisition, and resources. ML, FL, XW, ZL, HW, and YZ: investigation. ML, FL, and XW: formal analysis. ML: writing—original draft preparation. FL and XW: writing—review and editing. FL and DW: supervision. ML and DW: project administration. All authors contributed to the article and approved the submitted version.

Funding

This study received financial support from the National Natural Science Foundation of China (81000703 and 81472896), the Natural Science Foundation of Jiangsu Province (BK2009437), and the Six Talent Peaks of Jiangsu Province (2015-WSW-026).

Acknowledgments

We thank the associated patients for donated tissue and the volunteers for their participation in the pathological and immunohistochemical studies.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Baran R, Perrin C. Localized multinucleate distal subungual keratosis. Br J Dermatol. (1995) 133:77–82. doi: 10.1111/j.1365-2133.1995.tb02496.x

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Baran R, Perrin C. Longitudinal erythronychia with distal subungual keratosis: onychopapilloma of the nail bed and Bowen’s disease. Br J Dermatol. (2000) 143:132–5. doi: 10.1046/j.1365-2133.2000.03602.x

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Tosti A, Schneider SL, Ramirez-Quizon MN, Zaiac M, Miteva M. Clinical, dermoscopic, and pathologic features of onychopapilloma: a review of 47 cases. J Am Acad Dermatol. (2016) 74:521–6. doi: 10.1016/j.jaad.2015.08.053

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Kim M, Sun EY, Jung HY, Cho BK, Park HJ. Onychopapilloma: a report of three cases presenting with various longitudinal chromonychia. Ann Dermatol. (2016) 28:655–7. doi: 10.5021/ad.2016.28.5.655

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Inaoki M, Makino E, Adachi M, Fujimoto W. Onycholemmal carcinoma. J Cutan Pathol. (2006) 33:577–80. doi: 10.1111/j.1600-0560.2006.00482.x

PubMed Abstract | CrossRef Full Text | Google Scholar

6. De Berker D, Wojnarowska F, Sviland L, Westgate GE, Dawber RP, Leigh IM. Keratin expression in the normal nail unit: markers of regional differentiation. Br J Dermatol. (2000) 142:89–96. doi: 10.1046/j.1365-2133.2000.03246.x

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Perrin C. Expression of follicular sheath keratins in the normal nail with special reference to the morphological analysis of the distal nail unit. Am J Dermatopathol. (2007) 29:543–50. doi: 10.1097/DAD.0b013e318158d741

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Perrin C, Langbein L, Schweizer J. Expression of hair keratins in the adult nail unit: an immunohistochemical analysis of the onychogenesis in the proximal nail fold, matrix and nail bed. Br J Dermatol. (2004) 151:362–71. doi: 10.1111/j.1365-2133.2004.06108.x

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Heid HW, Moll I, Franke WW. Patterns of expression of trichocytic and epithelial cytokeratins in mammalian tissues. I. Human and bovine hair follicles. Differentiation. (1988) 37:137–57. doi: 10.1111/j.1432-0436.1988.tb00805.x

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Ito T, Uchi H, Yamada Y, Oda Y, Furue M. Onychopapilloma manifesting longitudinal melanonychia: a mimic of subungual malignancy. J Dermatol. (2015) 42:1199–201. doi: 10.1111/1346-8138.13097

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Halteh P, Magro C, Scher RK, Lipner SR. Onychopapilloma presenting as leukonychia: case report and review of the literature. Skin Appendage Disord. (2017) 2:89–91. doi: 10.1159/000448105

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Beggs S, Butala N, Heymann WR, Rubin AI. Onychopapilloma presenting as longitudinal erythronychia in an adolescent. Pediatr Dermatol. (2015) 32:e173–4. doi: 10.1111/pde.12599

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Haneke E. Important malignant and new nail tumors. J Dtsch Dermatol Ges. (2017) 15:367–86. doi: 10.1111/ddg.13223

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Cribier B, Peltre B, Langbein L, Winter H, Schweizer J, Grosshans E. Expression of type I hair keratins in follicular tumors. Br J Dermatol. (2001) 144:977–82. doi: 10.1046/j.1365-2133.2001.04185.x

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: onychopapilloma, nail, hair-related keratins, epithelial keratins, immunohistochemical study

Citation: Liu M, Li F, Wang X, Liu Z, Wong HS, Zhou Y and Wang D (2022) Expression patterns of hair-related keratins and epithelial keratins in onychopapilloma: The significance of clarifying the origin of onychopapilloma. Front. Med. 9:1059624. doi: 10.3389/fmed.2022.1059624

Received: 01 October 2022; Accepted: 07 November 2022;
Published: 22 November 2022.

Edited by:

Müzeyyen Gönül, Dışkapı Yildirim Training and Research Hospital, Turkey

Reviewed by:

Flavia Persechino, San Gallicano Hospital, Italy
Siliang Xue, Sichuan University, China
Han Ma, The Fifth Affiliated Hospital of Sun Yat-sen University, China

Copyright © 2022 Liu, Li, Wang, Liu, Wong, Zhou and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Daguang Wang, wangirwin@126.com

These authors have contributed equally to this work and share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.